Wells Fargo’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $89K | Sell |
5,094
-8,217
| -62% | -$163K | ﹤0.01% | 5166 |
|
|
2025
Q4 | $261K | Buy |
13,311
+3,655
| +38% | +$75.8K | ﹤0.01% | 4911 |
|
|
2025
Q3 | $266K | Buy |
9,656
+285
| +3% | +$8.77K | ﹤0.01% | 4765 |
|
|
2025
Q2 | $286K | Buy |
9,371
+325
| +4% | +$9.23K | ﹤0.01% | 4538 |
|
|
2025
Q1 | $244K | Buy |
9,046
+1,085
| +14% | +$34.4K | ﹤0.01% | 4558 |
|
|
2024
Q4 | $286K | Buy |
7,961
+2,082
| +35% | +$77.9K | ﹤0.01% | 4565 |
|
|
2024
Q3 | $223K | Buy |
5,879
+192
| +3% | +$7.89K | ﹤0.01% | 4497 |
|
|
2024
Q2 | $257K | Buy |
5,687
+1,397
| +33% | +$64.3K | ﹤0.01% | 4343 |
|
|
2024
Q1 | $208K | Buy |
4,290
+811
| +23% | +$39.7K | ﹤0.01% | 4448 |
|
|
2023
Q4 | $186K | Buy |
3,479
+596
| +21% | +$30.1K | ﹤0.01% | 4500 |
|
|
2023
Q3 | $169K | Sell |
2,883
-3,533
| -55% | -$221K | ﹤0.01% | 4468 |
|
|
2023
Q2 | $404K | Buy |
6,416
+2,342
| +57% | +$149K | ﹤0.01% | 4109 |
|
|
2023
Q1 | $256K | Buy |
4,074
+522
| +15% | +$31.1K | ﹤0.01% | 4287 |
|
|
2022
Q4 | $189K | Sell |
3,552
-2,056
| -37% | -$111K | ﹤0.01% | 4201 |
|
|
2022
Q3 | $314K | Buy |
5,608
+2,294
| +69% | +$152K | ﹤0.01% | 3976 |
|
|
2022
Q2 | $239K | Sell |
3,314
-7,560
| -70% | -$563K | ﹤0.01% | 4182 |
|
|
2022
Q1 | $864K | Sell |
10,874
-5,963
| -35% | -$538K | ﹤0.01% | 4016 |
|
|
2021
Q4 | $1.7M | Sell |
16,837
-20,361
| -55% | -$2.03M | ﹤0.01% | 3654 |
|
|
2021
Q3 | $3.43M | Sell |
37,198
-23,543
| -39% | -$2.27M | ﹤0.01% | 3196 |
|
|
2021
Q2 | $6.22M | Sell |
60,741
-31,215
| -34% | -$3.13M | ﹤0.01% | 2657 |
|
|
2021
Q1 | $8.98M | Buy |
91,956
+6,797
| +8% | +$619K | ﹤0.01% | 2294 |
|
|
2020
Q4 | $6.57M | Sell |
85,159
-493
| -0.6% | -$38.1K | ﹤0.01% | 2476 |
|
|
2020
Q3 | $6.31M | Buy |
85,652
+5,444
| +7% | +$437K | ﹤0.01% | 2293 |
|
|
2020
Q2 | $5.89M | Buy |
80,208
+47,430
| +145% | +$3.72M | ﹤0.01% | 2318 |
|
|
2020
Q1 | $1.89M | Buy |
32,778
+7,842
| +31% | +$545K | ﹤0.01% | 3051 |
|
|
2019
Q4 | $1.96M | Sell |
24,936
-14,625
| -37% | -$1.08M | ﹤0.01% | 3364 |
|
|
2019
Q3 | $2.71M | Sell |
39,561
-7,411
| -16% | -$498K | ﹤0.01% | 3069 |
|
|
2019
Q2 | $3.73M | Sell |
46,972
-28,599
| -38% | -$2.27M | ﹤0.01% | 2828 |
|
|
2019
Q1 | $6.34M | Sell |
75,571
-76
| -0.1% | -$7.93K | ﹤0.01% | 2329 |
|
|
2018
Q4 | $8.91M | Buy |
75,647
+1,171
| +2% | +$135K | ﹤0.01% | 1935 |
|
|
2018
Q3 | $8.98M | Sell |
74,476
-5,857
| -7% | -$727K | ﹤0.01% | 2162 |
|
|
2018
Q2 | $9.26M | Sell |
80,333
-30,368
| -27% | -$3.32M | ﹤0.01% | 2135 |
|
|
2018
Q1 | $9.51M | Buy |
110,701
+6,033
| +6% | +$467K | ﹤0.01% | 2054 |
|
|
2017
Q4 | $7.75M | Buy |
104,668
+36,967
| +55% | +$2.47M | ﹤0.01% | 2191 |
|
|
2017
Q3 | $3.91M | Buy |
67,701
+40,420
| +148% | +$2.39M | ﹤0.01% | 2746 |
|
|
2017
Q2 | $1.75M | Sell |
27,281
-4,199
| -13% | -$259K | ﹤0.01% | 3311 |
|
|
2017
Q1 | $1.81M | Buy |
31,480
+13,044
| +71% | +$779K | ﹤0.01% | 3283 |
|
|
2016
Q4 | $1.13M | Buy |
18,436
+848
| +5% | +$55.3K | ﹤0.01% | 3612 |
|
|
2016
Q3 | $1.22M | Sell |
17,588
-5,710
| -25% | -$377K | ﹤0.01% | 3347 |
|
|
2016
Q2 | $1.3M | Sell |
23,298
-1,262
| -5% | -$76.1K | ﹤0.01% | 3288 |
|
|
2016
Q1 | $1.49M | Sell |
24,560
-22,882
| -48% | -$1.35M | ﹤0.01% | 3127 |
|
|
2015
Q4 | $3.03M | Buy |
47,442
+3,694
| +8% | +$240K | ﹤0.01% | 2676 |
|
|
2015
Q3 | $2.93M | Buy |
43,748
+11,756
| +37% | +$831K | ﹤0.01% | 2716 |
|
|
2015
Q2 | $2.19M | Buy |
31,992
+2,410
| +8% | +$153K | ﹤0.01% | 3036 |
|
|
2015
Q1 | $1.64M | Buy |
29,582
+1,290
| +5% | +$66.1K | ﹤0.01% | 3180 |
|
|
2014
Q4 | $1.45M | Sell |
28,292
-3,366
| -11% | -$165K | ﹤0.01% | 3254 |
|
|
2014
Q3 | $1.17M | Sell |
31,658
-9,940
| -24% | -$359K | ﹤0.01% | 3378 |
|
|
2014
Q2 | $1.63M | Sell |
41,598
-1,060
| -2% | -$39.3K | ﹤0.01% | 3138 |
|
|
2014
Q1 | $1.61M | Buy |
42,658
+19,924
| +88% | +$696K | ﹤0.01% | 3142 |
|
|
2013
Q4 | $859K | Sell |
22,734
-92,348
| -80% | -$3.53M | ﹤0.01% | 3506 |
|
|
2013
Q3 | $4.99M | Buy |
115,082
+16,390
| +17% | +$658K | ﹤0.01% | 2196 |
|
|
2013
Q2 | $3.57M | Buy |
+98,692
| New | +$3M | ﹤0.01% | 2377 |
|
Other funds holding USNA
NCM
VCM
VPM
Wells Fargo's USNA Position: Q1 2026 in Review
Wells Fargo reduced its Usana Health Sciences (USNA) stake by 62% in Q1 2026, selling an estimated $163K and leaving 5,094 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #5166.
Wells Fargo first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.51M in Q1 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Wells Fargo held 5,094 shares of Usana Health Sciences worth $89K as of Q1 2026.
- Wells Fargo sold 8,217 Usana Health Sciences shares in Q1 2026, an estimated $163K.
- Usana Health Sciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5166 holding.
- Wells Fargo first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Usana Health Sciences position peaked at $9.51M in Q1 2018.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.